Avistone is an oncology company focused on developing innovative therapies for patients with significant unmet medical needs globally.  Avistone has an extensive pipeline of targeted therapies including two clinical-stage drug candidates and several ongoing programs in the pre-clinical development stage.  The Company's lead asset is PLB1001, a small-molecule inhibitor that targets MET tyrosine kinase activity, including aberrant activity observed with METexon14 skipping (genetic) alterations in NSCLC tumors and in other solid tumors.  The company's second clinical asset is PLB1004, a potent inhibitor of EGFR tyrosine kinases (TKI), including aberrant activity observed with EGFR exon20 insertion (genetic) mutations in NSCLC tumors.

Avistone Biotechnology Co., Inc

Chief Business Officer

Chief Strategy Officer, BioShin

Vice President, Business Development

Senior Director, Strategy & Corporate Development

Director, Portfolio Strategy & Operations, Global Commercialization

Director, Strategic Transactions

Manager, New Business Development

Director, Clinical Operations

Director

Associate Director

Senior Manager Clinical Operations

Project Manager

Senior Clinical Research Associate

Senior Clinical Trial Asssistant

Site Relations Specialist

Research Assistant; Traumatic Brain Injury Model System Project

Bootstrap Framework

Mobile Friendly

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times.We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Sr Director Clinical Strategy and Optimization (Medical Device)

Patient Recruitment Assistant

Senior Statistical Programmer I

Clinical Trial Assistant

ICON plc

Akamai

Cloudflare DNS

Mimecast

Microsoft Office 365

Amazon AWS

Brightcove

PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world's most advanced healthcare  intelligence  and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical  research works, because we know that trials can be done smarter, better and faster.

PRA Health Sciences

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

Nurse Educator/Clinical Educator

Rare Disease Key Account Manager - Pacific Northwest-3069921

Talent Acquistion Specialist

IQVIA

Outlook

Oracle Cloud

VueJS

Amazon SES

OneTrust

Stroke, brain injury, and other central nervous system disorders can impair movement, language, information processing, and other abilities. Such disabilities result in loss of independence, substantial economic costs, and emotional burdens. Moss Rehabilitation Research Institute is devoted to improving the lives of individuals with neurological disabilities through research.Research at MRRI occupies a unique position within a translational "pipeline" from basic neuroscience to clinical neuroscience and neurorehabilitation.- We perform basic research, framed by theoretical perspectives, that maintains contact with the complexities of real-world functioning and leads to advances in neurorehabilitation assessment and treatment.- We perform patient-based research that informs basic science theories of complex cognitive and motor functioning and their neural bases and on the processes of change in these systems.

Brendan Putz

Director, Clinical Operations at Avistone Biotechnology Co., Inc

Brendan Putz's Professional Contact Details

Brendan Putz's Current Company Details

Avistone Biotechnology Co., Inc

Brendan Putz's Work History and Education

Frequently Asked Questions about Brendan Putz

What company does Brendan Putz work for?

What is Brendan Putz's role at Avistone Biotechnology Co., Inc?

What is Brendan Putz's email address?

What is Brendan Putz's business email address?

What is Brendan Putz's direct mobile number?

What industry does Brendan Putz work in?

Who are Brendan Putz's colleagues?

Colleagues at Avistone Biotechnology Co., Inc

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?